Australia · Delayed Price · Currency is AUD Biotron Statistics
Total Valuation
Biotron has a market cap or net worth of AUD 5.57 million. The enterprise value is 4.02 million.
| Market Cap | 5.57M |
| Enterprise Value | 4.02M |
Important Dates
The last earnings date was Thursday, September 3, 2026.
| Earnings Date | Sep 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biotron has 2.79 billion shares outstanding. The number of shares has increased by 107.51% in one year.
| Current Share Class | 2.79B |
| Shares Outstanding | 2.79B |
| Shares Change (YoY) | +107.51% |
| Shares Change (QoQ) | +76.47% |
| Owned by Insiders (%) | 25.17% |
| Owned by Institutions (%) | 0.42% |
| Float | 1.96B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.59 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 7.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.94
| Current Ratio | 1.94 |
| Quick Ratio | 1.92 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -87.44% and return on invested capital (ROIC) is -56.01%.
| Return on Equity (ROE) | -87.44% |
| Return on Assets (ROA) | -41.22% |
| Return on Invested Capital (ROIC) | -56.01% |
| Return on Capital Employed (ROCE) | -53.27% |
| Weighted Average Cost of Capital (WACC) | 0.76% |
| Revenue Per Employee | 175,290 |
| Profits Per Employee | -506,101 |
| Employee Count | 3 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is -0.63, so Biotron's price volatility has been lower than the market average.
| Beta (5Y) | -0.63 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 47.36 |
| Average Volume (20 Days) | 6,323,739 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biotron had revenue of AUD 525,869 and -1.52 million in losses. Loss per share was -0.00.
| Revenue | 525,869 |
| Gross Profit | 525,869 |
| Operating Income | -1.56M |
| Pretax Income | -1.52M |
| Net Income | -1.52M |
| EBITDA | -1.55M |
| EBIT | -1.56M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 1.55 million in cash and no debt, with a net cash position of 1.55 million or 0.00 per share.
| Cash & Cash Equivalents | 1.55M |
| Total Debt | n/a |
| Net Cash | 1.55M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 2.92M |
| Book Value Per Share | 0.00 |
| Working Capital | 767,421 |
Cash Flow
| Operating Cash Flow | -1.78M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1,913 |
| Net Borrowing | n/a |
| Free Cash Flow | -1.78M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of -295.91% and -288.72%.
| Gross Margin | 100.00% |
| Operating Margin | -295.91% |
| Pretax Margin | -288.72% |
| Profit Margin | -288.72% |
| EBITDA Margin | -295.55% |
| EBIT Margin | -295.91% |
| FCF Margin | n/a |
Dividends & Yields
Biotron does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -107.51% |
| Shareholder Yield | -107.51% |
| Earnings Yield | -27.26% |
| FCF Yield | -31.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biotron has an Altman Z-Score of -19.17. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.17 |
| Piotroski F-Score | n/a |